Skip to content

Clinical trials

Withdrawn Congenital Abnormalities trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Congenital Abnormalities Status: Withdrawn Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20042
20061
20083
20091
20122
20132
20141
20151
20171
20181
20201
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Medicine and Dentistry of New Jersey3
M.D. Anderson Cancer Center2
Alliance for Clinical Trials in Oncology1
Case Comprehensive Cancer Center1
Croma-Pharma GmbH1
Eastern Cooperative Oncology Group1
Hospital Universitario San Ignacio1
Johns Hopkins University1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Congenital Abnormalities23
Leukemia, Myeloid, Acute16
Precursor Cell Lymphoblastic Leukemia-Lymphoma13
Leukemia, Lymphocytic, Chronic, B-Cell10
Leukemia, Myeloid, Accelerated Phase10
Lymphoma, B-Cell, Marginal Zone10
Lymphoma, Follicular10
Lymphoma, Mantle-Cell10
Lymphoma, Non-Hodgkin10
Myeloproliferative Disorders10

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.